PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Counterfeit Drugs - Decisive and Global Action is Needed - In a market where counterfeit drug sales are estimated to reach $75 billion by 2010 according to the World Health Organisation (WHO), it is clear that drug counterfeiting is on the increase
Counterfeit Drugs - Decisive and Global Action is Needed

 

NewswireToday - /newswire/ - London, United Kingdom, 2008/04/29 - In a market where counterfeit drug sales are estimated to reach $75 billion by 2010 according to the World Health Organisation (WHO), it is clear that drug counterfeiting is on the increase.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Fraud/Identity Theft/Piracy Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!

World needs to know about google malpractices - Share your Adsense publishers stories on Google tactics to steal your revenues

 

Yet there is too much talk and not enough decisive action being taken in the industry to harness this problem, which is affecting national economies, damaging pharmaceutical brands and above all threatening patient safety, concludes a new study by Frost & Sullivan (healthcare.frost.com)

The study, commissioned by patient safety communications company Aegate, entitled Working Together on Mass Serialisation: Whose Responsibility is Ensuring Patient Safety?, reviews the steps that have been taken to try and address this burgeoning issue both from a national legislative level and through the use of new technologies. The analysis concludes that as counterfeit medicines impact patients’ health and have such a negative effect on all involved in the supply chain, a collective push towards a solution with tangible benefits for all parties is urgently needed.

“It is Frost & Sullivan’s opinion that with the current growth of the counterfeit drug market, the industry needs to stop talking about finding a solution and start working together to put one in place,” says Frost & Sullivan Vice President - Financial and Business Services, Europe and Africa Andrew Calvert. “To do this successfully there needs to be an acceptance right across the supply chain of shared liability.”

Frost & Sullivan believes that mass serialisation, a process by which a unique number is assigned to each saleable unit (pallet, case or individual package of drugs), can provide the foundation to develop a workable solution to help combat the trade in counterfeit drugs.

It is important to note however, that the application of the mass serialisation technology alone will not make a difference. It only provides the key to authentication processes that can validate drugs at critical points in the pharmaceutical supply chain, which can often involve more than 20 stages. This enables the assurance of product quality before dispensing and the opportunity to identify sources within the supply chain at which counterfeits may have leaked in.

Although there are costs involved in setting up mass serialisation systems, pharmaceutical companies and governments stand to benefit from a secure supply chain, improved product recall, brand protection, point of sale security, and improved service to pharmacists and patients. However, with a few notable exceptions, the industry has been slow to recognise the rewards of this approach.

“With mass serialisation ready and accessible to make a difference now, the industry is running out of excuses for not facing up to their moral responsibilities and putting patients first,” Calvert says.

The WHO and the European Federation of Pharmaceutical Industries and Associations (EFPIA) are however working to encourage adoption. In addition, Frost & Sullivan identified that countries such as Belgium and Greece, who are early adopters of mass serialisation, have seen great benefits.

However, while mass serialisation provides an effective and immediately available solution, its impact will not be felt on the global stage if it is only embraced by individual market participants or at a country level. In an increasingly globalised world, solutions to combat the trade in counterfeits must be globally applied.

The report concludes that an element of compulsion and collective action is needed by all market participants to combat drug counterfeiting and to drive interest and uptake in patient safety solutions that make use of mass serialisation. The responsibility for this ultimately rests with Governments who have the power to enact legislation.

“We applaud moves by individual stakeholders to help combat counterfeit drugs, however we support Frost and Sullivan’s findings,” says CEO of Aegate, Gary Noon. “The industry as a whole still needs to do more to eradicate this alarming trend. We are committed to playing our role in supporting the industry, by having a workable authentication solution available now that will enable collective responsibility to be taken for the benefit of the patient. Aegate has patient safety at the heart of what we do.”

If you are interested in receiving more information on the study Working Together on Mass Serialisation: Whose Responsibility is Ensuring Patient Safety? and on our Growth Partnership Services, then send an e-mail to Patrick Cairns - Corporate Communications at pcairns_pr[.]frost.com with your full name, company name, title, telephone number, email address, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.

About Aegate

Aegate (aegate.com) provides a unique patient safety network that opens a direct, IT enabled communications channel between pharmacies and pharmaceutical companies. The channel communicates real time pertinent information at the time of dispense. For pharmaceutical companies they can utilise the Aegate network to reach the pharmacy (and patients) directly with communications at the time their products are being dispensed. Whilst for the pharmacist it offers assurance that good quality medicines are being delivered to patients via the distribution of relevant and timely information at the time of dispensing - increasing confidence in patient safety. Aegate has been trading since 2003 and is backed by PA Consulting Group.

About Frost & Sullivan

Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Fraud/Identity Theft/Piracy Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!

World needs to know about google malpractices - Share your Adsense publishers stories on Google tactics to steal your revenues

 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Fraud/Identity Theft/Piracy articles,
CATCH Visitors via Your Competitors Announcements!


Counterfeit Drugs - Decisive and Global Action is Needed

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Patrick Cairns 
+27 18 468 2315 patrick.cairns[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Fraud/Identity Theft/Piracy via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Fraud/Identity Theft/Piracy Most Recent Related Newswires:

More Than 1 Million Google Accounts Breached by Gooligan, New Android Malware Variant
Bitdefender Adds Enhanced Anti-Exploit Technologies to Enterprise Product Line to Fend off Modern Threats
EGIDE Announces its Participation At the 2nd International Vandagraf Brand Protection Conference 2016
Subex Awarded Pipeline Innovation Award 2016 for Security & Assurance
Jolly Good Media Joins a Nationwide Effort to Support Data Privacy Day by Signing On as a Champion
DSM and Large Global E-commerce Platforms Collaborate to Stamp Out Dyneema® Trademark Infringements
No Fraud, LLC Launches A New Approach to eCommerce Fraud Prevention
Mires, Ran, and Clark Announces Addition of Certified Fraud Examiner to Growing Team of Specialists
Zumigo Selected by AlwaysOn as One of the 2015 OnFinance Companies to Watch
Five Sparrows Provides Businesses Test for Google Mobile Readiness
CANIPRE Introduces A Uniquely Canadian Approach to Anti-Piracy & Content Protection
Technology Heavyweight Matt Banham Joins mPayments Innovators Omlis as Chief Technology Officer
Omlis and Stratus Technologies Establish Strategic Presence in Mexico
Omlis and ISN Strike A Hot Partnership in Chile
LexisNexis® Announces Enhanced International Capabilities for its One Time Password Authentication Solution

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)